Loading
Sentiment · FY2026 Q1
What companies say about each other on earnings calls — extracted verbatim from public transcripts. Mentions from the newest quarter are a Pro feature.
“Obviously, Prologis has a very robust and high-quality fund business. We're watching and seeing what Realty Income does with their fund business. Welltower is diversified.”
VICI references Welltower's diversification as a peer REIT example while thinking through the evolution of the REIT/asset-management model.
“we've now seen Welltower raise their fund”
An analyst cites Welltower's recent capital raise for its investment fund business as a comparison point when asking Invitation Homes about its appetite for larger third-party capital vehicles.
“We're incredibly grateful to Adia and our other LPs who have entrusted us with their capital in this new endeavor.”
Abu Dhabi Investment Authority (ADIA) is a limited partner backing Welltower's new Senior Housing Equity Fund, a read-through on sovereign capital appetite for senior housing.
“we embarked on an arduous process of recapitalizing this portfolio with Integra, which then brought its network of regional and local operators to turn the portfolio around.”
Integra is Welltower's operating partner that recapitalized and turned around its skilled-nursing (former HCR ManorCare/QCP) portfolio, driving a $500M cash-flow rebound.
“the previously announced $3.2 billion Amica Senior Lifestyle transaction”
Welltower's $3.2B acquisition of the Amica Senior Lifestyle portfolio, a major senior housing acquisition anchoring its 2026 investment activity.
“Our previously announced $7.2 billion outpatient medical sale to Kayne Anderson, which generated a $1.9 billion gain on sale”
Welltower is selling its $7.2B outpatient medical portfolio to Kayne Anderson, a large divestiture read-through (Kayne Anderson expanding in medical office real estate).
“we will exit the OM Property Management business with over 160 of our colleagues transitioning to Remedy Medical properties, allowing them to continue their career growth”
Remedy Medical Properties is the counterparty taking over Welltower's exited outpatient medical property-management business and staff.
“We are pleased to announce the GBP 1.2 billion acquisition of the HC-One portfolio in the U.K.”
Welltower converts its HC-One loan position into GBP 1.2 billion equity ownership of the UK care-home portfolio after a ~14% IRR on the original investment.
“our GBP 5.2 billion acquisition of Barchester which spans 3 buckets”
Welltower's GBP 5.2 billion Barchester acquisition is a major UK senior-living portfolio addition across RIDEA, triple-net and development assets.
“following the current rating upgrade we received last quarter from both S&P and Moody's to A, our balance sheet has trended even farther.”
Moody's upgraded Welltower's credit rating to A the prior quarter, a routine rating action cited as part of the company's balance-sheet strengthening.
“following the current rating upgrade we received last quarter from both S&P and Moody's to A, our balance sheet has trended even farther.”
S&P upgraded Welltower's credit rating to A the prior quarter, a routine rating action cited as part of the company's balance-sheet strengthening.
“Including the previously announced $3.2 billion Amica transaction.”
Welltower's $3.2 billion acquisition of Amica is cited as a substantial portion of the company's acquisitions-under-contract expected to close in the fourth quarter.
“I was yesterday with one of my strongest operating partners, StoryPoint, in Toledo, where we are now.”
Welltower CEO Shankh Mitra singles out StoryPoint as one of the company's strongest operating partners, citing the owner's personal financial investment in the business through a difficult five-year stretch.
“For background, Holiday was acquired in 2021 at a price we believe to represent an extraordinary value but so far, it has turned out to be our biggest capital allocation mistake by yours truly.”
Welltower's 2021 acquisition of the Holiday senior-housing portfolio is characterized by CEO Shankh Mitra as the company's biggest capital allocation mistake and a failure so far, prompting the transition of the roughly 10,000-unit portfolio to six other regional operators.
| Analyst | Firm | Questions (Challenge)Percentage of questions scored as challenging — where the analyst pushed back, pressed for specifics, or questioned management's assumptions. |
|---|---|---|
| Juan Sanabria | BMO Capital Markets | 6 (0%) |
| Mike Mueller | JPMorgan | 6 (0%) |
| Mike Carroll | RBC Capital Markets | 6 (0%) |
| Ron Kamdem | Morgan Stanley | 6 (0%) |
| Vikram Malhotra | Mizuho Securities | 6 (0%) |
| Nick Yulico | Scotiabank | 6 (0%) |
| Austin Wurschmidt | KeyBanc Capital Markets | 6 (0%) |
| Jim Kammert | Evercore ISI | 5 (0%) |
| Jon Hughes | Raymond James | 5 (20%) |
| Rich Anderson | Wedbush Securities | 5 (0%) |
| Firm | Analysts | Questions (Challenge)Percentage of questions scored as challenging — where the analyst pushed back, pressed for specifics, or questioned management's assumptions. |
|---|---|---|
| Mizuho Securities | 2 | 7 (0%) |
| Green Street | 3 | 7 (0%) |
| Citigroup | 2 | 6 (0%) |
| BMO Capital Markets | 1 |
| 6 (0%) |
| Morgan Stanley | 1 | 6 (0%) |
| JPMorgan | 1 | 6 (0%) |
| KeyBanc Capital Markets | 1 | 6 (0%) |
| RBC Capital Markets | 1 | 6 (0%) |
Welltower closed a transformational FY2025 with its thirteenth consecutive quarter of 20%+ SHO NOI growth, delivering full-year revenue growth of 36% and FFO per share growth of 22%. Management introduced FY2026 normalized FFO guidance of $6.09-$6.25 per share while launching a private funds management business with a $2.5B equity fund. The Integra portfolio exit generated a 25% unlevered IRR and 3.1x multiple, and 2026 was already off to a strong start with $5.7B in acquisitions closed or under contract.
Competitive Dynamics | Capital Allocation | Demand | Revenue Growth | Innovation & R&D | M&A | Pricing | Margin | |
|---|---|---|---|---|---|---|---|---|
| 2024Q4 | 5 | 2 | 6 | 2 | 1 | 2 | 2 | 2 |
| 2025Q1 | 2 | 3 | 4 | 1 | 3 | 3 | 2 | 2 |
| 2025Q2 | 4 | 3 | 5 | 5 | 2 | 1 | 1 | 2 |
| 2025Q3 | 10 | 6 | 2 | 3 | 4 | 2 | ||
| 2025Q4 | 4 | 5 | 4 | 4 | 2 | 2 | 3 | 3 |
| 2026Q1 | 7 | 6 | 2 | 2 | 5 | 1 | 1 | 1 |
| '24Q4 | '25Q1 | '25Q2 | '25Q3 | '25Q4 | '26Q1 | |
|---|---|---|---|---|---|---|
| Competitive Dynamics | 5 | 2 | 4 | 10 | 4 | 7 |
| Capital Allocation | 2 | 3 | 3 | 6 | 5 | 6 |
| Demand | 6 | 4 | 5 | 4 | 2 | |
| Revenue Growth | 2 | 1 | 5 | 2 | 4 | 2 |
| Innovation & R&D | 1 | 3 | 2 | 3 | 2 | 5 |
| M&A | 2 | 3 | 1 | 4 | 2 | 1 |
| Pricing | 2 | 2 | 1 | 2 | 3 | 1 |
| Margin | 2 | 2 | 2 | 3 | 1 |
| Company | Score | Trend | Rev YoY |
|---|---|---|---|
WELL Welltower | 8 | +40.3% | |
| DOC Healthpeak Properties | 6 | +7.1% | |
| VTR Ventas | 8 | +22.0% |